Skip to main content
Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
16.38
+1.14 (7.48%)
Apr 29, 2026, 4:08 PM HKT

HKG:2591 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2025 FY 2024 FY 2023
Period Ending
 Apr '26 Dec '25 Dec '24 Dec '23
Market Capitalization
7,48313,997--
Enterprise Value
6,32713,255--
Last Close Price
16.3830.64--
PS Ratio
51.1395.64--
PB Ratio
6.3811.94--
P/TBV Ratio
6.5212.19--
EV/Sales Ratio
43.2490.57--
Debt / Equity Ratio
0.160.160.010.07
Net Debt / Equity Ratio
-0.99-0.99-0.99-0.92
Net Debt / EBITDA Ratio
3.123.124.500.88
Net Debt / FCF Ratio
--4.723.67
Asset Turnover
0.110.11--
Inventory Turnover
0.200.20--
Quick Ratio
2.672.675.821.94
Current Ratio
2.932.936.072.66
Return on Equity (ROE)
-36.91%-36.91%-23.27%-
Return on Assets (ROA)
-17.30%-17.30%-11.61%-
Return on Capital Employed (ROCE)
-32.50%-32.50%-23.80%-100.30%
Earnings Yield
-5.08%-2.71%--
Buyback Yield / Dilution
-3.44%-3.44%-9.63%-
Source: S&P Capital IQ. Standard template. Financial Sources.